106 related articles for article (PubMed ID: 1587007)
1. Involvement of prostaglandin E2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis.
Yamamoto S; Jiang H; Otsuka C; Kato R
Carcinogenesis; 1992 May; 13(5):905-6. PubMed ID: 1587007
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice.
Nakadate T; Yamamoto S; Aizu E; Kato R
Carcinogenesis; 1989 Nov; 10(11):2053-7. PubMed ID: 2553289
[TBL] [Abstract][Full Text] [Related]
3. The potent anti-tumor-promoting agent isoliquiritigenin.
Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase.
Yamamoto S; Nakadate T; Aizu E; Kato R
Carcinogenesis; 1990 May; 11(5):749-54. PubMed ID: 2110512
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
6. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis.
Jiang H; Yamamoto S; Kato R
Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
Nakadate T; Yamamoto S; Ishii M; Kato R
Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors.
Nakadate T; Aizu E; Yamamoto S; Fujiki H; Sugimura T; Kato R
Jpn J Pharmacol; 1985 Mar; 37(3):253-8. PubMed ID: 3923244
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway.
Nakadate T; Yamamoto S; Ishii M; Kato R
Carcinogenesis; 1982; 3(12):1411-4. PubMed ID: 6817941
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
Weekes RG; Verma AK; Boutwell RK
Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 counteracts the inhibition by indomethacin of rat colon ornithine decarboxylase induction by deoxycholic acid.
Narisawa T; Hosaka S; Niwa M
Jpn J Cancer Res; 1985 May; 76(5):338-44. PubMed ID: 3924707
[TBL] [Abstract][Full Text] [Related]
12. Involvement of prostaglandin E2 in the tumor promoter phorbol ester-caused increase in epidermal cholesterol sulfotransferase activity.
Yamamoto S; Jiang H; Kato R
Carcinogenesis; 1991 Jun; 12(6):1145-7. PubMed ID: 2044198
[TBL] [Abstract][Full Text] [Related]
13. The modulation effect of vitamin E on prostaglandin E2 level and ornithine decarboxylase activity at the promotion phase of lung tumorigenesis in mice.
Yano T; Yano Y; Uchida M; Murakami A; Hagiwara K; Otani S; Ichikawa T
Biochem Pharmacol; 1997 Jun; 53(11):1757-9. PubMed ID: 9264330
[TBL] [Abstract][Full Text] [Related]
14. Induction of epidermal ornithine decarboxylase activity in mouse skin exposed to biogenic silica fibers.
Bhatt TS; Beltran L; Walker SE; DiGiovanni J
Carcinogenesis; 1992 Apr; 13(4):617-20. PubMed ID: 1315627
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
16. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
Kruszewski FH; Chenicek KJ; Digiovanni J
Cancer Lett; 1986 Sep; 32(3):263-9. PubMed ID: 3768852
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
DiGiovanni J; Kruszewski FH; Coombs MM; Bhatt TS; Pezeshk A
Carcinogenesis; 1988 Aug; 9(8):1437-43. PubMed ID: 3402040
[TBL] [Abstract][Full Text] [Related]
18. The role of prostaglandin E1 in ornithine decarboxylase induction by tumor promoters.
Ordman AB; Simsiman RC; Cleaveland JS; Boutwell RK
Int J Cancer; 1986 Mar; 37(3):445-9. PubMed ID: 3081453
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of increases in levels of 3':5'-cyclic AMP and 3':5'-cyclic GMP from induction of ornithine decarboxylase by the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate in mouse epidermis in vivo.
Mufson RA; Astrup EG; Simsiman RC; Boutwell RK
Proc Natl Acad Sci U S A; 1977 Feb; 74(2):657-61. PubMed ID: 191821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
